Literature DB >> 35803518

Characteristics and implications of Omicron variant associated digestive system infections - Correspondence.

Yunjie Shi1, Zubing Mei2, Hao Wang3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35803518      PMCID: PMC9258453          DOI: 10.1016/j.ijsu.2022.106750

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   13.400


× No keyword cloud information.
Dar Editor, South Africa first reported to the World Health Organization (WHO) the latest variant B.1.1.529 of SARS-CoV-2 in late November 2021. When compared with the other SARS-CoV-2 variants, the new variant carries a higher risk of infection and spreads faster, and was named by the WHO as “Omicron” [1].Since then, the Omicron variant BA.1 has been spreading rapidly worldwide, surpassing the previously dominant Delta variant [2]. Another variant of Omicron BA.2 was detected at the same time in several countries and regions, and its transmission ability even surpasses that of the variant BA.1. The effective reproduction number of the mutant BA.2 is 1.4 times that of the mutant BA.1, and the immunity induced by the currently available SARS-CoV-2 vaccines in the general population is ineffective against the mutant BA.2 in neutralization experiments [3]. Two other sub-variants of Omicron BA.4 and BA.5 have replaced BA.2 as the dominant strains in South Africa in the beginning of May 2022, and their transmission ability further increased. This Letter to Editor addresses the clinical characteristics and implications of digestive tract infection of the Omicron variant strains.

Pathogenic characteristics and clinical symptoms of Omicron variant infection

A new round of local SARS-CoV-2 outbreaks has occurred in Shanghai, China since late February 2022, and the virus genomes belong to the BA.2 variant of Omicron [4]。The cumulative number of infected people had reached more than 650,000 by late May 2022, and asymptomatic infection cases accounted for more than 90% of the total infected population. Deaths associated with this round of epidemic occurred mainly in elderly people over 60 years of age with a variety of serious underlying diseases and who had not been vaccinated or not fully vaccinated. All these show that the BA.2 variant of Omicron is very harmful to these elderly and also to children with weak immunity [3]. The most important way to curb asymptomatic infection of the Omicron variant strains is to cut off the chain of community transmission, and the Shanghai Government established several makeshift hospitals in various administrative regions to receive asymptomatically infected patients for isolation and treatment. The mean time for nucleic acid negative conversion is about 5–7 days. There is no specific symptom in the early stage of the disease. Mild upper respiratory tract irritation occurs 12–72 hours later, mainly presenting as sore throat and hoarseness. Gastrointestinal symptoms are rare. A prospective observational study which involved more than 60,000 SARS-CoV-2 patients in the United Kingdom showed patients infected with the Omicron variant were less likely to develop nasal congestion (hyposmia) than the Delta variant, while sore throat and hoarseness were more common. Complications of other organs such as gastrointestinal symptoms were relatively rare [2]. The possible reason for the strong transmissibility and mild symptoms of the Omicron variant is probably related to the crystal structure changes caused by more than 30 mutations in the virus Spike protein [5].

Omicron strains and childhood hepatitis

The experience in Shanghai showed gastrointestinal symptoms caused by Omicron variants to be relatively rare. Kei et al. demonstrated that the Omicron variant strain had a lower proliferation efficiency in the intestinal model. They assayed the viral RNA and titer in the culture supernatant and found that the Omicron variants had an extremely low replication capacity [6]. A large retrospective study on the Omicron outbreak in South Africa showed that the hospitalization rate in adolescents and children to be significantly higher than those reported in the previous outbreaks. Children under the age of 20 years accounted for 14.3% of the total number of hospitalized patients, and about 25.4% of infected children under the age of 5 years needed hospitalization [7]. In the United States, the hospitalization rate of children infected with Omicron was also reported to be high, and 19% infected children required ICU treatment [8]. The possible reasons are weak immunity, low vaccination rates, and high respiratory infection rates in adolescents and children. Recently, the United Kingdom, the United States, Japan and other countries reported unexplained acute hepatitis in children with a history of Omicron variant infection. The pathological cause may be due to continuous release of viral proteins from the Omicron variant that resides in the intestinal epithelium, resulting in production of “superantigens” which mediate multisystem inflammatory syndrome in children who present with fever, rash, vomiting and diarrhea. If an adenovirus is infected during this process, the influence of the “superantigen” becomes more obvious, resulting in abnormal immunity reaction and an outbreak of acute hepatitis [9]. Hiroshi et al. collected information on Omicron infection in 39 countries and found that countries with fulminant hepatitis in children also had a higher number of Omicron infections (p = 0.013). They postulated that previous exposure to Omicron variants increases the risk of developing severe hepatitis in children [10]. Although the Omicron variant is less replicable in intestinal epithelium, particular attention should be paid to infection of the Omicron variant in children because it can cause more serious complications.

Fecal excretion and sewage detection of Omicron strains

Notably, the SARS-CoV-2 virus can be isolated from the feces of more than half of infected individuals, suggesting that the SARS-CoV-2 virus can infect and replicate in the gut. Anal swab nucleic acid test results have gradually attracted our attention. For patients who were admitted to our hospital during the Shanghai epidemic, the positive rate of anal swabs from people infected with the Omicron strain was higher than those from people infected with the original COVID-19 strains. The results of anal swabs are now also used as one of the criteria to decide whether a patient should be discharged home. When the SARS-CoV-2 pandemic broke out globally at the beginning of 2020, the Wuhan Institute of Virology in China detected virus content in wastewater near designated quarantine hospitals, and also found the number of infected people was increased in regions where the virus content in wastewater was high, suggesting wastewater testing can serve as an early warning signal of gathering of infected persons. Since the outbreak of COVID-19, the Swedish Centre for Environmental Epidemiology has been conducting virus testing in Swedish urban wastewater to monitor the spread of the SARS-CoV-2 virus. Their results in February 2022 showed that the virus content of the Omicron variant surpassed that of the Delta variant [11]. The Department of Laws and Regulations of the National Health Commission of the People's Republic of China issued a notice on the “Standards for Novel Coronavirus Enrichment and Concentration in Sewage and Nucleic Acid Detection Methods” in April 2022, which standardizes nucleic acid sampling and detection methods in sewage [12]. The use of regional wastewater virus detection hopefully can quickly curb the spread of the virus in an early stage with the advantages of low cost, rapidity and high accuracy.

Summary

The Omicron variant has the characteristics of fast transmission, mild symptoms, and ease to cause regional cluster outbreaks. Special attention should be paid to the protection of immunocompromised people, the elderly and young children. To facilitate early detection and prevention of regional virus transmission, continual regional wastewater testing is recommended.

Please state whether ethical approval was given, by whom and the relevant Judgement's reference number

None.

Please state any sources of funding for your research

This work was supported by the first affiliated hospital of the Naval Medical University (COVID-ZD-013).

Author contribution

Please specify the contribution of each author to the paper, e.g. study design, data collections, data analysis, writing. Others, who have contributed in other ways should be listed as contributors. Yunjie Shi: Drafting of the manuscript. Zubing Mei: Conceptualization, Critical revision of the manuscript for important intellectual content. Hao Wang: Conceptualization, Study concept and design.

Please state any conflicts of interest

None.

Provenance and peer review

Not commissioned, internally peer-reviewed.

Research registration unique identifying number (UIN)

None.

Guarantor

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish. Please note that providing a guarantor is compulsory.

Data statement

This correspondence did not yield data and thus no data were available.
  10 in total

1.  Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.

Authors:  Daichi Yamasoba; Izumi Kimura; Hesham Nasser; Yuhei Morioka; Naganori Nao; Jumpei Ito; Keiya Uriu; Masumi Tsuda; Jiri Zahradnik; Kotaro Shirakawa; Rigel Suzuki; Mai Kishimoto; Yusuke Kosugi; Kouji Kobiyama; Teppei Hara; Mako Toyoda; Yuri L Tanaka; Erika P Butlertanaka; Ryo Shimizu; Hayato Ito; Lei Wang; Yoshitaka Oda; Yasuko Orba; Michihito Sasaki; Kayoko Nagata; Kumiko Yoshimatsu; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Jin Kuramochi; Motoaki Seki; Ryoji Fujiki; Atsushi Kaneda; Tadanaga Shimada; Taka-Aki Nakada; Seiichiro Sakao; Takuji Suzuki; Takamasa Ueno; Akifumi Takaori-Kondo; Ken J Ishii; Gideon Schreiber; Hirofumi Sawa; Akatsuki Saito; Takashi Irie; Shinya Tanaka; Keita Matsuno; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
Journal:  Cell       Date:  2022-05-02       Impact factor: 66.850

2.  Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.

Authors:  Caroline Maslo; Richard Friedland; Mande Toubkin; Anchen Laubscher; Teshlin Akaloo; Boniswa Kama
Journal:  JAMA       Date:  2022-02-08       Impact factor: 157.335

3.  Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens.

Authors:  Petter Brodin; Moshe Arditi
Journal:  Lancet Gastroenterol Hepatol       Date:  2022-05-14

4.  Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.

Authors:  Waasila Jassat; Salim S Abdool Karim; Caroline Mudara; Richard Welch; Lovelyn Ozougwu; Michelle J Groome; Nevashan Govender; Anne von Gottberg; Nicole Wolter; Milani Wolmarans; Petro Rousseau; Lucille Blumberg; Cheryl Cohen
Journal:  Lancet Glob Health       Date:  2022-05-18       Impact factor: 38.927

5.  Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.

Authors:  Cristina Menni; Ana M Valdes; Lorenzo Polidori; Michela Antonelli; Satya Penamakuri; Ana Nogal; Panayiotis Louca; Anna May; Jane C Figueiredo; Christina Hu; Erika Molteni; Liane Canas; Marc F Österdahl; Marc Modat; Carole H Sudre; Ben Fox; Alexander Hammers; Jonathan Wolf; Joan Capdevila; Andrew T Chan; Sean P David; Claire J Steves; Sebastien Ourselin; Tim D Spector
Journal:  Lancet       Date:  2022-04-07       Impact factor: 202.731

6.  SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.

Authors:  Yanan Zhang; Ting Zhang; Yihui Fang; Jie Liu; Qinong Ye; Lihua Ding
Journal:  Signal Transduct Target Ther       Date:  2022-03-09

7.  Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in "Mini-gut" Organoids.

Authors:  Kei Miyakawa; Masakazu Machida; Tomoyuki Kawasaki; Mayuko Nishi; Hidenori Akutsu; Akihide Ryo
Journal:  Gastroenterology       Date:  2022-04-29       Impact factor: 33.883

8.  Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.

Authors:  Dallas S Shi; Michael Whitaker; Kristin J Marks; Onika Anglin; Jennifer Milucky; Kadam Patel; Huong Pham; Shua J Chai; Breanna Kawasaki; James Meek; Evan J Anderson; Andy Weigel; Justin Henderson; Ruth Lynfield; Susan L Ropp; Alison Muse; Sophrena Bushey; Laurie M Billing; Melissa Sutton; H Keipp Talbot; Andrea Price; Christopher A Taylor; Fiona P Havers
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-04-22       Impact factor: 35.301

9.  Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.

Authors:  Xinxin Zhang; Wenhong Zhang; Saijuan Chen
Journal:  Lancet       Date:  2022-05-06       Impact factor: 79.321

10.  High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children.

Authors:  Hiroshi Nishiura; Sung-Mok Jung; Katsuma Hayashi
Journal:  Int J Infect Dis       Date:  2022-05-13       Impact factor: 12.074

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.